The National Comprehensive Cancer Network has issued updated guidelines for average-risk and high-risk colorectal cancer screening. READ MORE
Widespread use of alternative payment models may improve the quality of breast and colorectal cancer screening programs.
Differences in health insurance coverage account for about half of the substantial disparity in survival between black and white patients with colorectal cancer.
Testing for mismatch repair deficiency remains underused among adults with colorectal cancer, despite the existence of well-established guidelines aimed at high-risk populations.
The US Food and Drug Administration (FDA) has granted accelerated approval to a therapy for previously treated colorectal cancer.
Research in Review
A recent study compared the effects of first-line chemotherapy with two different drugs in patients with advanced or metastatic colorectal cancer.
Patients with colorectal cancer can decrease their risk of disease-related mortality by 54% if they consume certain types of food.
The National Comprehensive Cancer Network has issued updated guidelines for average-risk and high-risk colorectal cancer screening.
The United States Multi-Society Task Force of Colorectal Cancer has updated their recommendations for screening tests, ranking them into three “tiers,” published jointly in three gastroenterology journals.